From: ECMO after cardiac surgery: a single center study on survival and optimizing outcomes
Outcome | Non-survivors (N total = 37) | Survivors (n = N Total = 23) | p |
---|---|---|---|
Total hospital LOS (days) | 20 ± 1.5 | 35 ± 4.0 | 0.03 |
ECMO support (days) | 5.7 ± 0.73 | 4.8 ± 0.53 | 0.33 |
Blood product use while on ECMO (mean units of PRBCs ± STD) | 25 ± 2.3 | 13 ± 2.3 | 0.02 |
Bleeding events | 19 (51.3%) | 8 (34.7%) | 0.28 |
Net volume status (L mean ± STD) | 3.4 ± 1.6 | (−) 3.5 ± 1.5 | 0.01 |
Inotrope/vasopressor use | 20 (54.0% | 7 (30.4%) | 0.064 |
eCPR | 15 (83.3%) | 3 (16.6%) | 0.02 |
ECMO on the go | 4 (44.4%) | 5 (55.5%) | 0.29 |
OHT as salvage procedure | 0 | 4 | 0.018 |